Global Injectable Drug Delivery Devices Market Expected to Witness a Sustainable Growth over 2013-2025 - QY Research

This report studies the Injectable Drug Delivery Devices market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effect. These devices are majorly used during treatment of diseases like cancer and diabetes.

Increasing cancer population is the major factor for the growth of the market. Global injectable drug delivery devices market is driven by rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, increasing use of biologics. Technological advancements, improving patient compliance, beneficial reimbursement policies, increasing healthcare awareness and increasing geriatric population has also contributed to the growth of the market. Whereas, risk of blood-borne infections, safety concerns regarding the use of injectable, introduction of the alternative drug delivery devices would restrain the growth of the market.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Injectable Drug Delivery Devices in these regions, from 2013 to 2025, covering

    North America (United States, Canada and Mexico)

    Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

    Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

    South America (Brazil etc.)

    Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

    Dickinson and Company

    Baxter International

    Schott

    Eli Lilly

    Pfizer

    Gerresheimer

    Terumo Corporation

    Antares Pharma

    Novo Nordik

    Sanofi

    Unilife Corporation

    Zogenix

    Hospira

    Presage Bioscience

    MicroCHIPS

    Pearl Therapeutics

    Genentech

    Bend Research

By the product type, the market is primarily split into

    Devices

    Formulation

By the end users/application, this report covers the following segments

    Immune Disorder

    Cancer

    Diabetes

    Other

The study objectives of this report are:

    To study and analyze the global Injectable Drug Delivery Devices market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

    To understand the structure of Injectable Drug Delivery Devices market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Injectable Drug Delivery Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the Injectable Drug Delivery Devices with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of Injectable Drug Delivery Devices submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

Request Sample Report and TOC@ http://www.qyresearchglobal.com/goods-1796055.html

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

QY Research Achievements:  

Year of Experience: 11 Years

Consulting Projects: 500+ successfully conducted so far

Global Reports: 5000 Reports Every Years

Resellers Partners for Our Reports: 150 + Across Globe

Global Clients: 34000+

Contact US

QY Research, INC.

Tina

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 295 2442

Email: sales@qyrsearchglobal.com

Web: www.qyresearchglobal.com

For other region, contact number given below

+86 108 294 5717 Beijing

+852 3062 8839 HK

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Room 2901 VILI International Building No.167 Linhe West Road

This release was published on openPR.